Spruce Biosciences, Inc. (SPRB) Debt by Year
Spruce Biosciences, Inc. carried $0 in long-term debt against $48.9M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Spruce Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SPRB Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SPRB Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $4.6M | $5.5M | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $124K-92.8% | $524K-75.2% | $923K-63.2% | $1.3M-54.5% | $1.7M-47.9% | $2.1M-42.7% |
| Cash & Equivalents | $96.3M+487.6% | $54.1M+111.1% | $48.9M+26.2% | $10.7M-82.2% | $16.4M-76.5% | $25.6M-68.4% | $38.8M-59.8% | $60.1M-39.2% | $69.7M-28.5% | $81.2M+9.8% | $96.3M+293.4% | $98.8M+356.4% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Spruce Biosciences, Inc. financials
Frequently Asked Questions
What was Spruce Biosciences, Inc.'s long-term debt in fiscal year 2025?
Spruce Biosciences, Inc. carried $0 in long-term debt against $48.9M in cash and equivalents at the end of fiscal year 2025.
How fast is Spruce Biosciences, Inc.'s long-term debt growing?
Spruce Biosciences, Inc. (SPRB) long-term debt fell by 100.0% year over year, from $124K to $0 in fiscal year 2025.
How has Spruce Biosciences, Inc.'s long-term debt changed over the years?
Across the 7 fiscal years this page covers, Spruce Biosciences, Inc. (SPRB) long-term debt went from $3.2M in fiscal year 2019 to $0 in fiscal year 2025.
What was Spruce Biosciences, Inc.'s long-term debt in the most recent quarter?
Spruce Biosciences, Inc. (SPRB) reported $4.6M in long-term debt in Q2 2026.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Spruce Biosciences, Inc. (SPRB) reported on that line in every period on record.